EXBIO Praha
EXBIO Praha is a Czech-based GMP manufacturer of monoclonal antibodies and flow cytometry reagents serving clinical diagnostic laboratories and academic, pharmaceutical, and biotechnology research institutions with over 4,000 catalog products, including IVDR-compliant clinical kits and a global distributor-distributed catalog.
- Company typePrivate
- Founded1990
- HeadquartersCentral, Hong Kong SAR China
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What EXBIO Praha does
EXBIO Praha, a.s. is a privately held Czech joint-stock company headquartered in Vestec near Prague, founded in 1990, that manufactures monoclonal antibodies and reagents for flow cytometry. The company operates with 101-250 employees from GMP-certified facilities and runs two principal product lines: a clinical diagnostics portfolio (CE IVD and RUO/GMP-graded kits, multicolor cocktails, single-color antibodies, lysing solutions, and application-specific diagnostic kits covering hematology, immunodeficiency, reproductive immunology, and allergy) and a research catalog of more than 2,600 antibodies plus accessory reagents and recombinant allergens. Underlying platforms include DryFlowEx dry-reagent kits with extended stability, KOMBITEST pre-optimized multicolor cocktails, SingleFlowEx Premium GMP-manufactured antibodies, and EXCELLYSE sample preparation buffers, with multiple clinical kits now compliant with EU Regulation 2017/746 (IVDR).
Revenue is generated through per-unit catalog sales of reagents and kits, supplemented by custom assay development and OEM/bulk commercial supply services. Pricing is displayed and transacted in USD, with single-color antibodies in the $396-$660 range per ml, multicolor cocktails around $792-$963 per 50 tests, and complete kits priced up to $1,749 per 25 tests; allergen extracts, mitogens, and lysing solutions occupy lower price points between $17 and $125. Distribution combines direct e-commerce through the company website with an international distributor network serving clinical laboratories, hospitals, and research institutions globally.
The customer base spans clinical diagnostic laboratories and academic, pharmaceutical, and biotechnology research institutions, addressing use cases such as PNH diagnostics, immunodeficiency screening, reproductive immunology, allergy testing, and broader immunological and cell-based research. The company is privately owned with no disclosed institutional investors or funding rounds, and self-describes as a "world leading" manufacturer of flow cytometry reagents based on its 4,000+ SKU catalog depth and GMP clinical manufacturing capability.
EXBIO Praha firmographics
Firmographics- Name
- EXBIO Praha
- Legal name
- EXBIO Praha, a.s.
- Website
- https://exbio.cz
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- EXBIO Praha is a Czech-based GMP manufacturer of monoclonal antibodies and flow cytometry reagents serving clinical diagnostic laboratories and academic, pharmaceutical, and biotechnology research institutions with over 4,000 catalog products, including IVDR-compliant clinical kits and a global distributor-distributed catalog.
- Ownership category
- akta.pro rank
Where EXBIO Praha is headquartered
LocationHeadquarters
- HQ city
- Central
- HQ country
- Hong Kong SAR China
- HQ region
- Asia
Offices1 record
Markets served
EXBIO Praha business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Product Sales: Sale of flow cytometry reagents including antibodies, kits, lysing solutions, and multicolor cocktails to clinical and research customers
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Single color antibodies - per unit pricing |
| Unit Pricing | Pay-as-you-go | Multicolor Cocktails - per test pricing |
| Unit Pricing | Pay-as-you-go | Kits - per kit pricing |
| Unit Pricing | Pay-as-you-go | Allergens - per unit pricing |
| Unit Pricing | Pay-as-you-go | Mitogens and reagents |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
EXBIO Praha product offering
Product offeringCore offering
EXBIO Praha manufactures and sells flow cytometry reagents including GMP-grade monoclonal antibody single reagents, dry-reagent multicolor assay kits, pre-optimized multicolor cocktails, RBC lysing solutions, mitogens, recombinant and natural allergen extracts, and research-grade antibodies. Products are offered both as CE IVD / IVDR-compliant clinical diagnostics for hospital and clinical labs and as research-use reagents for academic, pharmaceutical, and biotechnology customers, with custom assay development and OEM bulk supply available on request.
Product overview
EXBIO Praha is a world-leading manufacturer of flow cytometry reagents with over 4,000 off-the-shelf products. The company operates two main product lines: Clinical Products (IVD-grade, CE IVD and RUO/GMP compliant) and Research Products. Clinical offerings center on the SingleFlowEx Premium Antibodies (GMP-manufactured monoclonal antibodies for surface and intracellular staining), DryFlowEx dry reagent cocktail kits (TBNK, PNH, RBC C3d panels), KOMBITEST multicolor cocktails, EXCELLYSE lysing solutions, and application-specific diagnostic kits (TregFlowEx, CD34 QuantiFlowEx, BasoFlowEx, NKFlowEx, SpermFlowEx, ApoFlowEx). Research products include over 2,600 antibodies targeting CD antigens, blood group antigens, cytoskeleton/ECM proteins, MHC antigens, nuclear targets, and viral antigens, plus recombinant allergens and accessory reagents. Custom assay development and OEM bulk supply services complement the catalog. The portfolio supports clinical diagnostics (hematology, immunodeficiency, reproductive immunology, allergy) and research applications across FC, FC-IC, ICC, IHC, ELISA, WB, and IP methods.
Differentiator
Problem solved
Functional benefit
Products and services
- SingleFlowEx Premium Antibodies
Quantifiable outcome
- Products made in EXBIO facilities for worldwide use
- +2 more outcomes
Companies that use EXBIO Praha
Customer profileSegments3 records
Ideal customer profiles3 records
EXBIO Praha technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
EXBIO Praha partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- International DistributorscoreNetwork of international distribution partners serving global markets. Distributors provide local sales, support, and logistics for EXBIO products in their respective territories.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
EXBIO Praha competitors and assessment
Company assessmentBroad incumbents
- Abcam: Abcam (now part of Danaher) is one of the world's largest antibody manufacturers with deep catalogs of flow cytometry-validated antibodies serving academic, pharma, and clinical research markets.
- BD Biosciences: BD Biosciences dominates clinical flow cytometry with the FACSCanto and FACSDiscover instruments and broad reagent catalogs spanning multicolor cocktails, lysing solutions, and clinical IVD assays.
- Thermo Fisher Scientific (Antibodies & Reagents): Thermo Fisher supplies Invitrogen and eBioscience flow cytometry antibodies and reagents covering immunology, hematology, and cell biology applications directly comparable to EXBIO's research catalog.
- Beckman Coulter Life Sciences: Beckman Coulter (a Danaher company) is a major flow cytometry platform and reagent provider offering clinical IVD antibodies and panels across immunology, hematology, and reproductive immunology workflows.
Emerging players
- Cytek Biosciences: Cytek Biosciences is a newer entrant in spectral flow cytometry instruments and reagents, increasingly overlapping with EXBIO in full-spectrum immunophenotyping panels for clinical and research use.
Direct peers
- Bio-Rad Laboratories: Bio-Rad manufactures a broad portfolio of flow cytometry antibodies, reagents, and consumables for clinical and research use, directly competing with EXBIO across clinical hematology and immunology panels.
- Cell Signaling Technology: Cell Signaling Technology is a leading antibody manufacturer producing flow cytometry-validated antibodies and recombinant reagents for research and translational applications, similar in catalog approach to EXBIO.
- Miltenyi Biotec: Miltenyi Biotec manufactures REA antibodies, multicolor flow cytometry reagents, and clinical GMP-grade products, making it a direct competitor in the multicolor antibody and clinical reagent space.
- Sysmex Europe (Partec flow cytometry): Sysmex, via the former Partec business, supplies clinical flow cytometry instruments, IVD reagents, and antibodies for hematology and immunology laboratories in competition with EXBIO's clinical product lines.
- Agilent Technologies (Cell Analysis): Agilent provides flow cytometry reagents and CE-IVD antibody panels for clinical immunology applications through its cell analysis portfolio, positioning it as a comparable clinical flow reagent competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
EXBIO Praha social profiles
Digital presenceEXBIO Praha financial estimates
Financial estimateRevenue estimate
Valuation estimate
EXBIO Praha leadership team
Management profileNumber of profiles
Profiles1 record
EXBIO Praha funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EXBIO Praha M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EXBIO Praha
What does EXBIO Praha do?
EXBIO Praha manufactures and sells flow cytometry reagents including GMP-grade monoclonal antibody single reagents, dry-reagent multicolor assay kits, pre-optimized multicolor cocktails, RBC lysing solutions, mitogens, recombinant and natural allergen extracts, and research-grade antibodies. Products are offered both as CE IVD / IVDR-compliant clinical diagnostics for hospital and clinical labs and as research-use reagents for academic, pharmaceutical, and biotechnology customers, with custom assay development and OEM bulk supply available on request.
Is EXBIO Praha a public or private company?
EXBIO Praha is a private company. It is classified as unknown and is currently operating.
When was EXBIO Praha founded?
EXBIO Praha was founded in 1990. It employs 101 to 250 people.
Where is EXBIO Praha based?
EXBIO Praha is headquartered in Central, Hong Kong SAR China, in the Asia region.
How does EXBIO Praha make money?
One revenue line is on record: product Sales.
Who are EXBIO Praha's main competitors?
Broad incumbents on record are Abcam, BD Biosciences, Thermo Fisher Scientific (Antibodies & Reagents) and Beckman Coulter Life Sciences. Cytek Biosciences is listed as an emerging player. Direct peers are Bio-Rad Laboratories, Cell Signaling Technology, Miltenyi Biotec, Sysmex Europe (Partec flow cytometry) and Agilent Technologies (Cell Analysis).
Does EXBIO Praha have an API?
No public API is recorded for EXBIO Praha.